223 related articles for article (PubMed ID: 30586303)
1. Peptide-Based Nanoparticles to Rapidly and Efficiently "Wrap 'n Roll" siRNA into Cells.
Konate K; Dussot M; Aldrian G; Vaissière A; Viguier V; Neira IF; Couillaud F; Vivès E; Boisguerin P; Deshayes S
Bioconjug Chem; 2019 Mar; 30(3):592-603. PubMed ID: 30586303
[TBL] [Abstract][Full Text] [Related]
2. WRAP-based nanoparticles for siRNA delivery: a SAR study and a comparison with lipid-based transfection reagents.
Konate K; Josse E; Tasic M; Redjatti K; Aldrian G; Deshayes S; Boisguérin P; Vivès E
J Nanobiotechnology; 2021 Aug; 19(1):236. PubMed ID: 34380479
[TBL] [Abstract][Full Text] [Related]
3. A retro-inverso cell-penetrating peptide for siRNA delivery.
Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
[TBL] [Abstract][Full Text] [Related]
4. Cell-penetrating peptides for siRNA delivery to glioblastomas.
Srimanee A; Arvanitidou M; Kim K; Hällbrink M; Langel Ü
Peptides; 2018 Jun; 104():62-69. PubMed ID: 29684592
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the internalization mechanism of WRAP:siRNA nanoparticles.
Deshayes S; Konate K; Dussot M; Chavey B; Vaissière A; Van TNN; Aldrian G; Padari K; Pooga M; Vivès E; Boisguérin P
Biochim Biophys Acta Biomembr; 2020 Jun; 1862(6):183252. PubMed ID: 32135145
[TBL] [Abstract][Full Text] [Related]
7. Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.
Konate K; Lindberg MF; Vaissiere A; Jourdan C; Aldrian G; Margeat E; Deshayes S; Boisguerin P
Int J Pharm; 2016 Jul; 509(1-2):71-84. PubMed ID: 27224007
[TBL] [Abstract][Full Text] [Related]
8. Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nanoparticles-cell-penetrating peptide.
Dowaidar M; Nasser Abdelhamid H; Hällbrink M; Langel Ü; Zou X
J Biomater Appl; 2018 Sep; 33(3):392-401. PubMed ID: 30223733
[TBL] [Abstract][Full Text] [Related]
9. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
Furukawa K; Tanaka M; Oba M
Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
[TBL] [Abstract][Full Text] [Related]
10. Molecular parameters of siRNA--cell penetrating peptide nanocomplexes for efficient cellular delivery.
van Asbeck AH; Beyerle A; McNeill H; Bovee-Geurts PH; Lindberg S; Verdurmen WP; Hällbrink M; Langel U; Heidenreich O; Brock R
ACS Nano; 2013 May; 7(5):3797-807. PubMed ID: 23600610
[TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.
Asai T; Tsuzuku T; Takahashi S; Okamoto A; Dewa T; Nango M; Hyodo K; Ishihara H; Kikuchi H; Oku N
Biochem Biophys Res Commun; 2014 Feb; 444(4):599-604. PubMed ID: 24486551
[TBL] [Abstract][Full Text] [Related]
12. Bioreducible branched poly(modified nona-arginine) cell-penetrating peptide as a novel gene delivery platform.
Yoo J; Lee D; Gujrati V; Rejinold NS; Lekshmi KM; Uthaman S; Jeong C; Park IK; Jon S; Kim YC
J Control Release; 2017 Jan; 246():142-154. PubMed ID: 27170226
[TBL] [Abstract][Full Text] [Related]
13. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
Li H; Tsui TY; Ma W
Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
[TBL] [Abstract][Full Text] [Related]
14. VEGF siRNA Delivery by a Cancer-Specific Cell-Penetrating Peptide.
Lee YW; Hwang YE; Lee JY; Sohn JH; Sung BH; Kim SC
J Microbiol Biotechnol; 2018 Mar; 28(3):367-374. PubMed ID: 29316746
[TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery.
Wan Y; Moyle PM; Gn PZ; Toth I
Nanomedicine (Lond); 2017 Feb; 12(4):281-293. PubMed ID: 28093948
[TBL] [Abstract][Full Text] [Related]
16. A non-covalent peptide-based strategy for siRNA delivery.
Crombez L; Divita G
Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
[TBL] [Abstract][Full Text] [Related]
17. Design and characterization of a new peptide vector for short interfering RNA delivery.
Chen B; Xu W; Pan R; Chen P
J Nanobiotechnology; 2015 Jun; 13():39. PubMed ID: 26054932
[TBL] [Abstract][Full Text] [Related]
18. Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo.
Andaloussi SE; Lehto T; Mäger I; Rosenthal-Aizman K; Oprea II; Simonson OE; Sork H; Ezzat K; Copolovici DM; Kurrikoff K; Viola JR; Zaghloul EM; Sillard R; Johansson HJ; Said Hassane F; Guterstam P; Suhorutšenko J; Moreno PM; Oskolkov N; Hälldin J; Tedebark U; Metspalu A; Lebleu B; Lehtiö J; Smith CI; Langel U
Nucleic Acids Res; 2011 May; 39(9):3972-87. PubMed ID: 21245043
[TBL] [Abstract][Full Text] [Related]
19. Cell-Penetrating Peptides Delivering siRNAs: An Overview.
Falato L; Gestin M; Langel Ü
Methods Mol Biol; 2021; 2282():329-352. PubMed ID: 33928583
[TBL] [Abstract][Full Text] [Related]
20. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
Crombez L; Morris MC; Heitz F; Divita G
Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]